Key goals for building on 30 years of HIV/AIDS research

May 31, 2011 in HIV & AIDS

In the 30 years since the first reported cases of a mysterious illness now known as AIDS, researchers have made extraordinary advances in understanding, treating and preventing the disease. Now the challenge, according to experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is to build on those successes to control and, ultimately, end the HIV/AIDS pandemic.

In an article published online today by the , Anthony S. Fauci, M.D., NIAID Director, and Carl W. Dieffenbach, Ph.D., Director of the NIAID Division of AIDS, discuss three research and implementation goals they believe are key to successfully achieving the long-term objective of ending the HIV/AIDS pandemic:

  • Efficiently identify greater numbers of HIV-infected people earlier in the course of their disease through expanded voluntary HIV testing programs, and link them to appropriate care and antiretroviral treatment
  • Find innovative approaches to curing HIV/AIDS by eradicating or permanently suppressing the virus in infected people, thereby eliminating the need for lifelong antiretroviral therapy
  • Scale-up implementation of proven HIV prevention strategies, develop additional effective prevention strategies, such as a vaccine, and build on current successes in pre-exposure prophylaxis, microbicides and treatment-as-prevention to achieve a sustainable and comprehensive, combination HIV prevention strategy
In their paper, the authors explore the challenges and opportunities associated with each of these goals, noting that an integrated strategy combining a variety of effective public health tools is needed to successfully curb /AIDS in the future.

More information: CW Dieffenbach and AS Fauci. Thirty years of HIV and AIDS: Future challenges and opportunities. Annals of Internal Medicine (2011).

Provided by National Institutes of Health

send feedback to editors
not rated yet  

Rank not rated yet
Tags

annals of internal medicine, hiv tests, microbicide, hiv, aids
Related Stories
more news
Relevant PhysicsForums posts

More news stories

Mortality rates decrease, chronic disease rates increase among HIV+ ICU patients

The expanded use of antiretrovirals, potent drugs used to treat retroviral infections such as human immunodeficiency virus (HIV), has been linked to significant decreases in hospital mortality rates among severely ill HIV-positive(HIV+) ...

HIV & AIDS created 8 hours ago | popularity not rated yet | comments 0

Newly discovered breast milk antibodies help neutralize HIV

Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (3) | comments 1 | with audio podcast

Reactions to HIV drug have autoimmune cause, reports AIDS journal

Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according ...

HIV & AIDS created May 22, 2012 | popularity not rated yet | comments 0

Is the U.S. ready for home HIV tests?

At the pharmacy, you can buy anything from tea kettles to Tylenol. But what if you could buy a rapid HIV test over the counter and test yourself in the privacy of your own home?

HIV & AIDS created May 21, 2012 | popularity not rated yet | comments 0 | with audio podcast

Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use

A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In lab ...

HIV & AIDS created May 17, 2012 | popularity 5 / 5 (1) | comments 0


The Goldilocks effect: Babies learn from experiences that are 'just right'

Long before babies understand the story of Goldilocks, they have more than mastered the fairy tale heroine's method of decision-making. Infants ignore information that is too simple or too complex, focusing instead on situations ...

Aspirin may prevent recurrence of deep vein blood clots

(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, ...

Intrauterine devices, implants most effective birth control

A study to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than ...

Women trying to have babies face different clock problem

A new Northwestern University study shows that the biological clock is not the only clock women trying to conceive should consider. The circadian clock needs attention, too.

Study shows how immune cells change wiring of the developing mouse brain

Researchers have shown in mice how immune cells in the brain target and remove unused connections between brain cells during normal development. This research, supported by the National Institutes of Health, sheds light on ...

Whole genome sequencing of rare olfactory neuroblastoma

The Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma ...